NCT02790294

Brief Summary

This research study is evaluating suitability of a delayed magnetic resonance imaging (MRI) in management of spine tumors. Currently the standard of care is obtaining an MRI scan in the early postoperative period (within 72 hours after surgery). The purpose of this study is to see if delayed MRI (2 to 3 weeks after surgery) is similar in quality to the earlier MRI. In this study patients will undergo 2 MRIs after the surgery instead of one MRI. Patients will have one MRI about 3 days after the surgery and one MRI about 2-3 weeks after surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 31, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 3, 2016

Completed
3 months until next milestone

Study Start

First participant enrolled

August 31, 2016

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 17, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 17, 2020

Completed
Last Updated

May 14, 2024

Status Verified

May 1, 2024

Enrollment Period

4.3 years

First QC Date

May 31, 2016

Last Update Submit

May 10, 2024

Conditions

Keywords

magnetic resonance imaging

Outcome Measures

Primary Outcomes (1)

  • Number of patients which have the same clinical decision from the immediate postoperative MRI and later imaging

    Assess if Magnetic Resonance Imaging (MRI) at 2 to 3 weeks after surgery (aka: later imaging) leads to the same clinical decisions and has the same probability of being chosen by a physician for guiding the subsequent management of the patient, compared with immediately postoperative MRI (within 72 hours, aka: early imaging).

    Up to 3 weeks after surgery

Secondary Outcomes (3)

  • Change in tumor volume between immediate and later postoperative MRI

    Up to 3 weeks after surgery

  • Difference in level of discomfort as measured by a visual analog scale between postoperative MRIs

    Up to 3 weeks after surgery

  • Progression of tumor using RECIST Criteria

    Up to 3 weeks after surgery

Study Arms (1)

Postoperative Magnetic Resonance Imaging

EXPERIMENTAL

Three MRIs will be performed. One at baseline, one within 72 hours postoperative, and one 2-3 weeks postoperative.

Device: Magnetic Resonance Imaging

Interventions

The routine spine MRI protocol will be utilized, which includes the following sequences: haste localizer, sagittal T1, T2, and short-T1 Inversion Recovery (STIR), axial T2 for lumbar spine or axial gradient echo for cervical and thoracic spine, axial T1, post contrast sagittal and axial T1. All scans will be obtained using a 1.5 Tesla magnet.

Also known as: MRI
Postoperative Magnetic Resonance Imaging

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Metastatic or primary malignant tumor involving spinal column, with or without extension into the epidural space
  • Operated for debulking, decompression or separation surgery;
  • A magnetic resonance imaging (MRI) scan performed within 72 hours after surgery is needed;
  • Image quality acceptable for comparison with later MRI as read by a neuroradiologist;
  • Karnofsky score of 60 or higher;
  • Able to consent for the study.

You may not qualify if:

  • Any patient who previously underwent spinal surgery at these levels will be excluded to eliminate late postoperative changes.
  • Intradural extension of the tumor.
  • Patients, whose MRI at post operative 48-72 hours are not readable due to artifacts or disease process shall not be included in the study.
  • Patient not able to tolerate MRI scan due to claustrophobia or severe pain or allergic reaction to contrast.
  • Patients with an estimated Glomerular Filtration Rate (eGFR) \< or = to 30 will be excluded to avoid issues related to contrast administration in such patients. This Glomerular Filtration Rate (GFR) threshold cutoff level is chosen per institutional policy, because below that level other measures would be required (hydration or no contrast administration). In order to keep the imaging information as uniform as possible in such a small study group, patients with a low GFR will not be enrolled in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center

Cleveland, Ohio, 44195, United States

Location

MeSH Terms

Conditions

Spinal Cord Neoplasms

Interventions

Magnetic Resonance Imaging

Condition Hierarchy (Ancestors)

Central Nervous System NeoplasmsNervous System NeoplasmsNeoplasms by SiteNeoplasmsSpinal Cord DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

TomographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Lilyana Angelov, MD

    Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 31, 2016

First Posted

June 3, 2016

Study Start

August 31, 2016

Primary Completion

December 17, 2020

Study Completion

December 17, 2020

Last Updated

May 14, 2024

Record last verified: 2024-05

Locations